These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 14044760)

  • 1. THE EFFECT OF A REPOSITORY PREPARATION OF THE DIHYDROTRIAZINE METABOLITE OF CHLORGUANIDE, CI-501, AGAINST THE CHESSON STRAIN OF PLASMODIUM VIVAX IN MAN.
    COATNEY GR; CONTACOS PG; LUNN JS; KILPATRICK JW; ELDER HA
    Am J Trop Med Hyg; 1963 Jul; 12():504-8. PubMed ID: 14044760
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of cycloguanil pamoate (CI-501) against a chlorguanide-resistant Chesson strain of Plasmodium vivax.
    Chin W; Lunn JS; Buxbaum J; Contacos PG
    Am J Trop Med Hyg; 1965 Nov; 14(6):922-4. PubMed ID: 5320455
    [No Abstract]   [Full Text] [Related]  

  • 3. FURTHER OBSERVATIONS ON THE ANTIMALARIAL ACTIVITY OF CI-501 (CAMOLAR) AGAINST THE CHESSON STRAIN OF VIVAX MALARIA.
    COATNEY GR; CONTACOS PG; LUNN JS
    Am J Trop Med Hyg; 1964 May; 13():383-5. PubMed ID: 14159973
    [No Abstract]   [Full Text] [Related]  

  • 4. An evaluation of CI-564 against blood-induced chlorguanide-sensitive and chlorguanide-resistant strains of vivax malaria.
    Chin W; Coatney GR; King HK
    Am J Trop Med Hyg; 1967 Jan; 16(1):13-4. PubMed ID: 5336629
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies in human malaria. XXVIII. Observations on the use of chloroguanide against the Chesson strain of Plasmodium vivax.
    COOPER WC; COATNEY GR; JEFFERY GM; IMBODEN CA
    J Natl Malar Soc; 1950 Dec; 9(4):366-76. PubMed ID: 14804096
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies in human malaria. XXXIV. Acquired resistance to pyrimethamine (daraprim) by the Chesson strain of plasmodium vivax.
    HERNANDEZ T; MYATT AV; COATNEY GR; JEFFERY GM
    Am J Trop Med Hyg; 1953 Sep; 2(5):797-804. PubMed ID: 13092368
    [No Abstract]   [Full Text] [Related]  

  • 7. Antimalarial activities of triazine metabolites of chlorguanide and dichlorguanide.
    SCHMIDT LH; LOO TL; FRADKIN R; HUGHES HB
    Proc Soc Exp Biol Med; 1952 Jun; 80(2):367-70. PubMed ID: 14949053
    [No Abstract]   [Full Text] [Related]  

  • 8. Randomized, placebo-controlled trial of atovaquone/proguanil for the prevention of Plasmodium falciparum or Plasmodium vivax malaria among migrants to Papua, Indonesia.
    Ling J; Baird JK; Fryauff DJ; Sismadi P; Bangs MJ; Lacy M; Barcus MJ; Gramzinski R; Maguire JD; Kumusumangsih M; Miller GB; Jones TR; Chulay JD; Hoffman SL;
    Clin Infect Dis; 2002 Oct; 35(7):825-33. PubMed ID: 12228819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the antimalarial effects of cycloguanil pamoate (CI-501) in man.
    Powell RD; DeGowin RL; Eppes RB
    Am J Trop Med Hyg; 1965 Nov; 14(6):913-21. PubMed ID: 5320454
    [No Abstract]   [Full Text] [Related]  

  • 10. THERAPEUTIC TRIALS OF A DIHYDROXYNAPHTHALENE (377C54) AGAINST PLASMODIUMFALCIPARUM AND PLASMODIUM VIVAX INFECTIONS IN HUMAN VOLUNTEERS.
    CONTACOS PG; ELDER HA; COATNEY GR
    Am J Trop Med Hyg; 1963 Jul; 12():513-8. PubMed ID: 14044762
    [No Abstract]   [Full Text] [Related]  

  • 11. Tertian malaria (Plasmodium vivax and Plasmodium ovale) in two travelers despite atovaquone-proguanil prophylaxis.
    Jiménez BC; Navarro M; Huerga H; López-Román E; Mendoza A; López-Vélez R
    J Travel Med; 2006; 13(6):373-5. PubMed ID: 17107431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The specific features of imported Plasmodium vivax malaria, Chesson strain type].
    Rabinovich SA; Kondrashin AV; Tokmalaev AK; Makcakovskaia EV; Sadykova VD; Burchik MA; Begunova SV; Sergiev VP
    Med Parazitol (Mosk); 2012; (4):7-11. PubMed ID: 23437714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM VIET-NAM.
    POWELL RD; BREWER GJ; DEGOWIN RL; ALVING AS
    Bull World Health Organ; 1964; 31(3):379-92. PubMed ID: 14267747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intrinsic efficacy of proguanil against falciparum and vivax malaria independent of the metabolite cycloguanil.
    Kaneko A; Bergqvist Y; Takechi M; Kalkoa M; Kaneko O; Kobayakawa T; Ishizaki T; Björkman A
    J Infect Dis; 1999 Apr; 179(4):974-9. PubMed ID: 10068594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atovaquone/proguanil therapy for Plasmodium falciparum and Plasmodium vivax malaria in Indonesians who lack clinical immunity.
    Lacy MD; Maguire JD; Barcus MJ; Ling J; Bangs MJ; Gramzinski R; Basri H; Sismadi P; Miller GB; Chulay JD; Fryauff DJ; Hoffman SL; Baird JK
    Clin Infect Dis; 2002 Nov; 35(9):e92-5. PubMed ID: 12384852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cluster of Plasmodium vivax malaria in an expedition group to Ethiopia: prophylactic efficacy of atovaquone/proguanil on liver stages of P. vivax.
    Mavrogordato A; Lever AM
    J Infect; 2012 Sep; 65(3):269-74. PubMed ID: 22609735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acquired resistance to proguanil in Plasmodium vivax.
    SEATON DR; LOURIE EM
    Lancet; 1949 Mar; 1(6549):394. PubMed ID: 18112625
    [No Abstract]   [Full Text] [Related]  

  • 18. Proguanil-resistance in Malayan strains of Plasmodium vivax.
    WILSON T; MUNRO DS; RICHARD DR
    Br Med J; 1952 Mar; 1(4758):564-8. PubMed ID: 14904984
    [No Abstract]   [Full Text] [Related]  

  • 19. LABORATORY STUDIES ON THE REPOSITORY ANTIMALARIAL ACTIVITY OF 4,4'-DIACETYLAMINODIPHENYLSULFONE, ALONE AND MIXED WITH CYCLOGUANIL PAMOATE (CI-501).
    THOMPSON PE; OLSZEWSKI B; WAITZ JA
    Am J Trop Med Hyg; 1965 May; 14():343-53. PubMed ID: 14292737
    [No Abstract]   [Full Text] [Related]  

  • 20. STUDIES ON A STRAIN OF CHLOROQUINE-RESISTANT PLASMODIUM FALCIPARUM FROM THAILAND.
    POWELL RD; BREWER GJ; ALVING AS; MILLAR JW
    Bull World Health Organ; 1964; 30(1):29-44. PubMed ID: 14128765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.